We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$753M
AUM Growth
+$41.2M
Cap. Flow
+$4.34M
Cap. Flow %
0.58%
Top 10 Hldgs %
7.71%
Holding
486
New
109
Increased
122
Reduced
150
Closed
98

Sector Composition

Rank Sector Weight
1 Technology 15.46%
2 Healthcare 12.36%
3 Financials 10.67%
4 Consumer Discretionary 10.44%
5 Industrials 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAM icon
326
Pampa Energía
PAM
$4.41B
$600K 0.08%
+18,508
New +$516K
INO icon
327
Inovio Pharmaceuticals
INO
$69M
$591K 0.08%
5,282
V icon
328
Visa
V
$677B
$581K 0.08%
5,166
-2,970
-37% -$238K
WBA
329
DELISTED
Walgreens Boots Alliance
WBA
$562K 0.07%
6,966
-2,505
-26% -$204K
WU icon
330
Western Union
WU
$2.21B
$558K 0.07%
26,811
-13,189
-33% -$271K
TDG icon
331
TransDigm Group
TDG
$67.7B
$557K 0.07%
1,400
-864
-38% -$243K
AMT icon
332
American Tower
AMT
$80.4B
$553K 0.07%
+3,635
New +$416K
XONE
333
DELISTED
The ExOne Company
XONE
$553K 0.07%
+36,335
New +$455K
TSRO
334
DELISTED
TESARO, Inc.
TSRO
$552K 0.07%
+5,506
New +$514K
BMY icon
335
Bristol-Myers Squibb
BMY
$132B
$530K 0.07%
9,837
-89
-0.9% -$5.72K
PG icon
336
Procter & Gamble
PG
$339B
$528K 0.07%
5,884
-2,766
-32% -$240K
NTES icon
337
NetEase
NTES
$84.7B
$525K 0.07%
+10,900
New +$464K
ADAP
338
DELISTED
Adaptimmune Therapeutics
ADAP
$516K 0.07%
73,145
-427
-0.6% -$3.26K
UNP icon
339
Union Pacific
UNP
$174B
$512K 0.07%
+5,249
New +$491K
ABMD
340
DELISTED
Abiomed Inc
ABMD
$512K 0.07%
3,980
-2,496
-39% -$299K
NXTM
341
DELISTED
NxStage Medical Inc.
NXTM
$511K 0.07%
+20,435
New +$476K
BRK.B icon
342
Berkshire Hathaway Class B
BRK.B
$1.13T
$502K 0.07%
3,474
-22,433
-87% -$3.28M
CMCSA icon
343
Comcast
CMCSA
$90B
$502K 0.07%
15,134
-62,468
-80% -$2.08M
EW icon
344
Edwards Lifesciences
EW
$51.7B
$502K 0.07%
+12,483
New +$470K
LLY icon
345
Eli Lilly
LLY
$1.06T
$501K 0.07%
6,240
-2,464
-28% -$197K
STJ
346
DELISTED
St Jude Medical
STJ
$500K 0.07%
+6,268
New +$506K
ZAYO
347
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$498K 0.07%
+16,771
New +$485K
CCI icon
348
Crown Castle
CCI
$32.2B
$497K 0.07%
+5,271
New +$507K
EXPE icon
349
Expedia Group
EXPE
$37.3B
$497K 0.07%
4,259
-1,771
-29% -$200K
PM icon
350
Philip Morris
PM
$295B
$497K 0.07%
+5,115
New +$512K

Similar funds

Vident Investment Advisory's Q3 2016 Portfolio in Review

As of Q3 2016, Vident Investment Advisory held 486 positions worth $753M, up 5.8% from $712M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Vident Investment Advisory's Q3 2016 filing shows 109 new, 122 increased, 150 reduced and 98 closed positions. Its largest new stake was Credicorp: 20,406 shares worth $3.11M. The largest sale was Southwestern Energy Company, an estimated $4.17M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Vident Investment Advisory's largest Q3 2016 buy was Credicorp: 20,406 shares worth $3.11M.
  • Vident Investment Advisory added most to Sprint Corporation in Q3 2016, an estimated $2.91M increase.
  • Vident Investment Advisory's biggest Q3 2016 reduction was NVIDIA, cutting an estimated $4.14M.
  • Vident Investment Advisory fully exited Southwestern Energy Company in Q3 2016, selling an estimated $4.17M.
  • Vident Investment Advisory's ten largest holdings make up 7.7% of its $753M portfolio in Q3 2016.
  • Vident Investment Advisory opened 109 new positions and closed 98 in Q3 2016.
  • Vident Investment Advisory's portfolio value rose 5.8% quarter-over-quarter to $753M.

Based on Vident Investment Advisory's 13F filing for Q3 2016, filed 10 Nov 2016.